FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical firm with a market capitalization of $119.87 billion, announced today a 2.6% increase in its quarterly cash dividend.

While many Canadian stocks are trading at 52-week highs, these two top TSX stocks are undervalued, making them among the best ...

If you need to generate income from your investments, selecting securities or funds based on their current interest or dividend payouts might solve the immediate problem. But a strategy of increasing ...

For example, the recent F share price of $9.24 represents a price-to-book ratio of 0.8 and an annual dividend yield of 6.49% ...

The stock looks like a decent value, but it could be a bargain if management can execute. Its dividend checks all the boxes ...

The company's announcement that it was walking back its 2028 goals for smoke-free products warranted a closer look at its ...

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

Star Group continues to outperform with volume gains and solid earnings. See why SGU stock’s 12.16% return projection makes ...

Millions of Britons use the Stocks and Shares ISA as a way to build wealth and generate an income. However, many aren’t fully ...

Ares Capital reported Q4 earnings on Feb. 5, which highlighted leadership changes, solid financials, and a record net asset ...

(Reuters) - Netflix is considering a bid for Formula One's U.S. TV rights, according to a report from The Athletic on Friday.

Key Insights The projected fair value for Thakral is S$0.91 based on Dividend Discount Model Current share price ...